Some of us actually don't accept we were dumb investors in SO4. Bring on the class action as soon as the losses over 2018-2021 are quantified with the proposed sale later in 2022.
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans